Nabumetone Tablets, 500 mg, Second (Tentative Approval) Copley Pharmaceutical, ANDA 75-179 6/6/00 6/9/00 12/31/01 Nabumetone Tablets, 500 mg & 750 mg, Teva USA ANDA 75-189 S-01, S-02 9/24/01 4/9/03 Nabumetone Tablets, 500 mg & 750 mg, Teva USA ANDA 75-189 5/26/00 6/6/00 12/28/01 Nabumetone Tablets, 500 mg and 750 mg, , (Tentatively approved 12/24/98) Teva USA ANDA 75-189 12/24/98 12/24/98 Nabumetone Tablets, 500 mg and 750 mg, Eon Labs Manufacturing ANDA 75-280 2/25/02 4/10/03 Nabumetone Tablets, 500 mg and 750 mg, , Tentatively approved August 6 Eon Labs Manufacturing ANDA 75-280 8/6/98 8/7/98 Nabumetone Tablets, 500 mg and 750 mg, Invamed ANDA 75-590 2/25/02 Nabumetone Tablets, 500 mg and 750 mg, , Tentatively approved 3/21/01 Invamed ANDA 75-590 3/21/01 3/30/01 Nabumetone Tablets, 500 mg and 750 mg, IVAX ANDA 76-009 NABUMETONE Tablet; 750MG NABUMETONE COPLEY 075280 NABUMETONE Tablet; 500MG NABUMETONE EON 075280 NABUMETONE Tablet; 750MG NABUMETONE EON 019583 NABUMETONE Tablet; 500MG RELAFEN GLAXOSMITHKLINE 019583 NABUMETONE Tablet; 750MG RELAFEN GLAXOSMITHKLINE 075590 NABUMETONE Tablet; 500MG NABUMETONE INVAMED 075590 NABUMETONE Tablet; 750MG NABUMETONE INVAMED 076009 NABUMETONE Tablet; 500MG NABUMETONE IVAX 076009 NABUMETONE Tablet; 750MG NABUMETONE IVAX 075189 NABUMETONE Tablet; 500MG NABUMETONE TEVA 075189 NABUMETONE Tablet; 750MG NABUMETONE TEVA